Hisamitsu Pharmaceutical co.,inc.

News Release Management and Personnel

2025.05.22

Executive Appointments
News Release lR Information

2025.05.22

Notice Regarding Cancellation of Treasury Shares
News Release Other

2025.05.16

Salonpas_® Named the World’s No. 1 OTC Topical Analgesic Patch Brand for the Ninth Consecutive Year
News Release Management and Personnel

2025.04.10

Executive Appointments
News Release lR Information

2025.04.10

FY02/2025 Q4 Results Earnings Release Presentation

News Release Management and Personnel

2025.05.22

Executive Appointments
News Release lR Information

2025.05.22

Notice Regarding Cancellation of Treasury Shares
News Release Other

2025.05.16

Salonpas_® Named the World’s No. 1 OTC Topical Analgesic Patch Brand for the Ninth Consecutive Year
News Release Management and Personnel

2025.04.10

Executive Appointments
News Release lR Information

2025.04.10

FY02/2025 Q4 Results Earnings Release Presentation

More

Notice

2021.09.07

Notice regarding the outbreak status of COVID-19 infection
Notice

2021.08.18

Notification Regarding Honorary Chairman, Hisamitsu Pharmaceutical Co., Inc. Passes Away
Notice

2021.05.06

Measures to Prevent the Spread of COVID-19 at the 119th Annual General Meeting of Shareholders
Notice

2020.11.09

Notification of Voluntary Recall for Overseas Pharmaceutical Drug “SALONPAS_®” (2 Patches)
Notice

2020.07.03

Notification of Voluntary Recall for Topical Analgesic Patch “SALONPAS HOT_®” (Category 3 OTC Drug in Japan)

More